You are here: Home » PTI Stories » National » News
Business Standard

USFDA closes inspection of Alkem's St Louis manufacturing facility

Press Trust of India  |  New Delhi 

Drug firm Tuesday said the American health regulator has issued an Establishment Inspection Report (EIR) for the company's St Louis (US) based manufacturing facility.

The facility was inspected by the Food and Drug Administration (USFDA) from March 12, 2018 to March 16, 2018, said in a BSE filing.

"In response to the Form 483 issued by the USFDA containing one observation, the company had submitted a detailed corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines," it added.

The inspection has now been closed by the USFDA, said.

Shares of Alkem Laboratories today closed at Rs 1,900 per scrip on the BSE, down 0.02 per cent from its previous close.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, December 04 2018. 17:30 IST